Harriet Rothschild

776 total citations
19 papers, 156 citations indexed

About

Harriet Rothschild is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Harriet Rothschild has authored 19 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 8 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Harriet Rothschild's work include Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (5 papers) and Breast Implant and Reconstruction (4 papers). Harriet Rothschild is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Breast Lesions and Carcinomas (5 papers) and Breast Implant and Reconstruction (4 papers). Harriet Rothschild collaborates with scholars based in United States, France and Switzerland. Harriet Rothschild's co-authors include Julien Ablain, Leonard I. Zon, Richard C. Jordan, Brianne H. Daniels, Caitlin Bell, Jeffrey K. Mito, Mengshu Xu, Nancy M. Joseph, Iwei Yeh and Boris C. Bastian and has published in prestigious journals such as Science, Nature Genetics and Annals of Surgical Oncology.

In The Last Decade

Harriet Rothschild

16 papers receiving 155 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harriet Rothschild United States 6 83 65 45 36 28 19 156
Tomáš Brychta Czechia 7 117 1.4× 92 1.4× 28 0.6× 28 0.8× 27 1.0× 14 190
Ville Kytölä Finland 5 68 0.8× 30 0.5× 33 0.7× 21 0.6× 21 0.8× 7 127
Mariko Nakano‐Okuno United States 7 171 2.1× 46 0.7× 67 1.5× 15 0.4× 15 0.5× 10 234
Marion Joy United States 7 85 1.0× 73 1.1× 39 0.9× 33 0.9× 52 1.9× 15 178
Nizar El-Murr France 7 146 1.8× 120 1.8× 74 1.6× 30 0.8× 33 1.2× 9 246
Sandra Duquesne Germany 5 109 1.3× 88 1.4× 51 1.1× 108 3.0× 26 0.9× 5 256
Tim van Groningen Netherlands 5 128 1.5× 71 1.1× 78 1.7× 25 0.7× 11 0.4× 7 214
Philip Bland United Kingdom 6 112 1.3× 34 0.5× 41 0.9× 16 0.4× 55 2.0× 8 210
Ayalur Raghu Subbalakshmi India 10 129 1.6× 107 1.6× 78 1.7× 24 0.7× 39 1.4× 18 235
Gal Haase Israel 7 112 1.3× 77 1.2× 42 0.9× 30 0.8× 29 1.0× 7 176

Countries citing papers authored by Harriet Rothschild

Since Specialization
Citations

This map shows the geographic impact of Harriet Rothschild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harriet Rothschild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harriet Rothschild more than expected).

Fields of papers citing papers by Harriet Rothschild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harriet Rothschild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harriet Rothschild. The network helps show where Harriet Rothschild may publish in the future.

Co-authorship network of co-authors of Harriet Rothschild

This figure shows the co-authorship network connecting the top 25 collaborators of Harriet Rothschild. A scholar is included among the top collaborators of Harriet Rothschild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harriet Rothschild. Harriet Rothschild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Rothschild, Harriet, Shoko Abe, Karen Goodwin, et al.. (2024). Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma. Annals of Surgical Oncology. 31(11). 7409–7417. 3 indexed citations
4.
Rothschild, Harriet, et al.. (2024). Variation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breast. Breast Cancer Research and Treatment. 208(3). 569–575. 1 indexed citations
5.
Rothschild, Harriet, Evan Lehrman, John C. Markley, et al.. (2024). Roadmap to safety: a single center study of evidence-informed approach to placenta accreta spectrum. Frontiers in Surgery. 11. 1347549–1347549. 2 indexed citations
6.
Rothschild, Harriet, et al.. (2023). Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes. Cancer Epidemiology Biomarkers & Prevention. 32(8). 1107–1113. 3 indexed citations
7.
Rothschild, Harriet, W. Fraser Symmans, Christopher J. Schwartz, et al.. (2023). Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes. Breast Cancer Research and Treatment. 202(2). 367–375. 1 indexed citations
8.
Rothschild, Harriet, Jasmine Wong, Laura J. Esserman, et al.. (2023). Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy. Annals of Surgical Oncology. 30(10). 5999–6006. 2 indexed citations
9.
Rothschild, Harriet, Mary Kathryn Abel, A. Jo Chien, et al.. (2023). The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB). Breast Cancer Research and Treatment. 203(2). 245–256. 2 indexed citations
10.
Rothschild, Harriet, et al.. (2023). HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series. Breast Cancer Research and Treatment. 199(2). 349–354. 8 indexed citations
11.
Rothschild, Harriet, et al.. (2023). Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment. Annals of Surgical Oncology. 30(12). 7099–7106. 3 indexed citations
12.
Rothschild, Harriet, A. Jo Chien, Michelle Melisko, et al.. (2023). Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer. npj Breast Cancer. 9(1). 88–88. 7 indexed citations
13.
14.
Rothschild, Harriet, et al.. (2023). Trust in prenatal exome sequencing for expectant families facing unexplained fetal anomalies. Prenatal Diagnosis. 44(3). 263–269.
15.
Ablain, Julien, Harriet Rothschild, Song Yang, et al.. (2022). Loss of NECTIN1 triggers melanoma dissemination upon local IGF1 depletion. Nature Genetics. 54(12). 1839–1852. 10 indexed citations
16.
Glencer, Alexa, Jasmine Wong, Nola M. Hylton, et al.. (2021). Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection. npj Breast Cancer. 7(1). 59–59. 7 indexed citations
17.
Rothschild, Harriet, Mary Kathryn Abel, Amy M. Shui, et al.. (2021). Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer. Breast Cancer Research and Treatment. 191(2). 451–458. 5 indexed citations
18.
Ablain, Julien, Mengshu Xu, Harriet Rothschild, et al.. (2018). Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma. Science. 362(6418). 1055–1060. 97 indexed citations
19.
Rothschild, Harriet, et al.. (1976). Regulation of the <i>β</i>-and <i>δ</i>-Hemoglobin Genes. Acta Haematologica. 56(5). 285–291. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomáš Brychta Breakdown of academic impact, for papers by Ville Kytölä Breakdown of academic impact, for papers by Mariko Nakano‐Okuno Breakdown of academic impact, for papers by Marion Joy Breakdown of academic impact, for papers by Nizar El-Murr Breakdown of academic impact, for papers by Sandra Duquesne Breakdown of academic impact, for papers by Tim van Groningen Breakdown of academic impact, for papers by Philip Bland Breakdown of academic impact, for papers by Ayalur Raghu Subbalakshmi Breakdown of academic impact, for papers by Gal Haase
Rankless by CCL
2026